{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:43:03Z","timestamp":1790678583929,"version":"4.1.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.beha.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T11:43:01Z","timestamp":1556883781000},"page":"163-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Hereditary myeloid malignancies"],"prefix":"10.1016","volume":"32","author":[{"given":"Hind","family":"Rafei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney D.","family":"DiNardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.beha.2019.05.001_bib1","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1200\/JCO.2009.25.2395","article-title":"Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries","volume":"28","author":"Goldberg","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.seminhematol.2017.04.004","article-title":"Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia","volume":"54","author":"Savage","year":"2017","journal-title":"Semin Hematol"},{"issue":"3\u20134","key":"10.1016\/j.beha.2019.05.001_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.beha.2014.10.002","article-title":"Fanconi anemia and the development of leukemia","volume":"27","author":"Alter","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.10255","article-title":"Severe chronic neutropenia: treatment and follow-up of patients in the severe chronic neutropenia international registry","volume":"72","author":"Dale","year":"2003","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jpeds.2013.11.039","article-title":"Variable clinical presentation of shwachman-diamond syndrome: update from the North American shwachman-diamond syndrome registry","volume":"164","author":"Myers","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.beha.2019.05.001_bib8","article-title":"Cancer predisposition in diamond Blackfan anemia: an update from the diamond Blackfan anemia Registry","volume":"63","author":"Vlachos","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.beha.2019.05.001_bib9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3324\/haematol.2016.149476","article-title":"Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients","volume":"101","author":"Keel","year":"2016","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.beha.2019.05.001_bib10","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.beha.2019.05.001_bib11","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2019.05.001_bib12","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1038\/ncomms10086","article-title":"Patterns and functional implications of rare germline variants across 12 cancer types","volume":"6","author":"Lu","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib13","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI91913","article-title":"Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans","volume":"127","author":"Buonocore","year":"2017","journal-title":"J Clin Investig"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib14","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajhg.2016.04.009","article-title":"Ataxia-pancytopenia syndrome is caused by Missense mutations in SAMD9L","volume":"98","author":"Chen","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"14","key":"10.1016\/j.beha.2019.05.001_bib15","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2016-05-670240","article-title":"How I diagnose and manage individuals at risk for inherited myeloid malignancies","volume":"128","author":"Drazer","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/2040620713487399","article-title":"Recognizing familial myeloid leukemia in adults","volume":"4","author":"Nickels","year":"2013","journal-title":"Ther Adv Hematol"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajhg.2010.12.006","article-title":"Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2","volume":"88","author":"Pippucci","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.beha.2019.05.001_bib19","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00431-015-2549-x","article-title":"Childhood diagnosis of genetic thrombocytopenia with mutation in the ankyrine repeat domain 26 gene","volume":"174","author":"Boutroux","year":"2015","journal-title":"Eur J Pediatr"},{"issue":"24","key":"10.1016\/j.beha.2019.05.001_bib20","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2019.05.001_bib21","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2013-04-499319","article-title":"ANKRD26-related thrombocytopenia and myeloid malignancies","volume":"122","author":"Noris","year":"2013","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.beha.2019.05.001_bib22","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa041331","article-title":"Mutation of CEBPA in familial acute myeloid leukemia","volume":"351","author":"Smith","year":"2004","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.beha.2019.05.001_bib23","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.3324\/haematol.2012.082578","article-title":"Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein alpha with 13 years difference at onset","volume":"98","author":"Debeljak","year":"2013","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.beha.2019.05.001_bib24","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2019.05.001_bib26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.beha.2019.05.001_bib27","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3324\/haematol.2011.041152","article-title":"Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications","volume":"96","author":"Calvo","year":"2011","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.beha.2019.05.001_bib28","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ajmg.a.33445","article-title":"Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases","volume":"152a","author":"Mansour","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"8","key":"10.1016\/j.beha.2019.05.001_bib29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bjh.13317","article-title":"Haematopoietic and immune defects associated with GATA2 mutation","volume":"169","author":"Collin","year":"2015","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib31","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2012-08-447367","article-title":"High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia","volume":"121","author":"Pasquet","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3324\/haematol.2013.090217","article-title":"Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation","volume":"99","author":"West","year":"2014","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.beha.2019.05.001_bib33","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ejhg.2008.89","article-title":"Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions","volume":"16","author":"Beri-Dexheimer","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"10.1016\/j.beha.2019.05.001_bib34","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/leu.2014.136","article-title":"Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD\/AML patients","volume":"28","author":"Sakurai","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/leu.2009.210","article-title":"Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD\/AML syndrome","volume":"24","author":"Jongmans","year":"2010","journal-title":"Leukemia"},{"issue":"22","key":"10.1016\/j.beha.2019.05.001_bib36","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1182\/blood-2008-07-168260","article-title":"High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder","volume":"113","author":"Preudhomme","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1042819031000139611","article-title":"Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia","volume":"45","author":"Ganly","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.beha.2019.05.001_bib38","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1182\/blood-2008-05-156745","article-title":"Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy","volume":"112","author":"Owen","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib39","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ajhg.2012.03.020","article-title":"Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia","volume":"90","author":"Kirwan","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib42","first-page":"400","article-title":"Nijmegen breakage syndrome. The international nijmegen breakage syndrome study group","volume":"82","year":"2000","journal-title":"Arch Dis Child"},{"issue":"4985","key":"10.1016\/j.beha.2019.05.001_bib43","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"issue":"9363","key":"10.1016\/j.beha.2019.05.001_bib44","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(03)12856-5","article-title":"Prediction of pathogenic mutations in patients with early-onset breast cancer by family history","volume":"361","author":"Lalloo","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.beha.2019.05.001_bib45","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","article-title":"Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations","volume":"27","author":"Gonzalez","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tig.2011.12.002","article-title":"The p53 network: cellular and systemic DNA damage responses in aging and cancer","volume":"28","author":"Reinhardt","year":"2012","journal-title":"Trends Genet"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: the growing complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"issue":"6381","key":"10.1016\/j.beha.2019.05.001_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"Cancer. p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"issue":"6250","key":"10.1016\/j.beha.2019.05.001_bib49","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/342705a0","article-title":"Mutations in the p53 gene occur in diverse human tumour types","volume":"342","author":"Nigro","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.beha.2019.05.001_bib50","series-title":"GeneReviews((R)). Seattle (WA)","article-title":"Li-fraumeni syndrome","author":"Schneider","year":"1993"},{"issue":"23","key":"10.1016\/j.beha.2019.05.001_bib51","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.beha.2019.05.001_bib52","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni syndrome from TP53 mutation carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib53","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/2040620713498161","article-title":"Genetic predispositions to childhood leukemia","volume":"4","author":"Stieglitz","year":"2013","journal-title":"Ther Adv Hematol"},{"issue":"26","key":"10.1016\/j.beha.2019.05.001_bib54","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1200\/JCO.2009.22.7967","article-title":"2009 version of the Chompret criteria for Li Fraumeni syndrome","volume":"27","author":"Tinat","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The genomic landscape of hypodiploid acute lymphoblastic leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.beha.2019.05.001_bib56","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.5858\/2009-0015-OA.1","article-title":"Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome","volume":"134","author":"Talwalkar","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","article-title":"Sensitivity and predictive value of criteria for p53 germline mutation screening","volume":"38","author":"Chompret","year":"2001","journal-title":"J Med Genet"},{"issue":"18","key":"10.1016\/j.beha.2019.05.001_bib58","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.beha.2019.05.001_bib59","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.beha.2019.05.001_bib60","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.296.12.1479","article-title":"Prediction of germline mutations and cancer risk in the Lynch syndrome","volume":"296","author":"Chen","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.beha.2019.05.001_bib61","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal cancer","volume":"348","author":"Lynch","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib62","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/jmedgenet-2014-102284","article-title":"Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD)","volume":"51","author":"Wimmer","year":"2014","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib63","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ejca.2013.12.005","article-title":"Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium","volume":"50","author":"Bakry","year":"2014","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib64","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jmedgenet-2013-102238","article-title":"Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium \"Care for CMMR-D\" (C4CMMR-D)","volume":"51","author":"Vasen","year":"2014","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmg.2015.12.014","article-title":"Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome","volume":"59","author":"Ripperger","year":"2016","journal-title":"Eur J Med Genet"},{"issue":"19","key":"10.1016\/j.beha.2019.05.001_bib66","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2016.66.6552","article-title":"Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency","volume":"34","author":"Bouffet","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ng.3202","article-title":"Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers","volume":"47","author":"Shlien","year":"2015","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.beha.2019.05.001_bib68","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1097\/MPH.0000000000000415","article-title":"Management of acute myeloblastic leukemia in a child with biallelic mismatch repair deficiency","volume":"37","author":"Elhasid","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib69","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/pbc.24019","article-title":"Oncologic surveillance for subjects with biallelic mismatch repair gene mutations: 10 year follow-up of a kindred","volume":"59","author":"Durno","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00005792-196605000-00001","article-title":"Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process","volume":"45","author":"Epstein","year":"1966","journal-title":"Medicine (Baltim)"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib71","first-page":"330","article-title":"Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group","volume":"60","author":"Yu","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib72","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/humu.20337","article-title":"The spectrum of WRN mutations in Werner syndrome patients","volume":"27","author":"Huang","year":"2006","journal-title":"Hum Mutat"},{"issue":"9166","key":"10.1016\/j.beha.2019.05.001_bib73","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(98)05869-3","article-title":"Prevalence of Werner's syndrome heterozygotes in Japan","volume":"353","author":"Satoh","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib74","first-page":"213","article-title":"Epidemiology and clinical aspects of Werner's syndrome in North Sardinia: description of a cluster","volume":"17","author":"Masala","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"10","key":"10.1016\/j.beha.2019.05.001_bib75","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/hmg\/ddw079","article-title":"The Werner syndrome RECQ helicase targets G4 DNA in human cells to modulate transcription","volume":"25","author":"Tang","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059709","article-title":"Spectrum and risk of neoplasia in Werner syndrome: a systematic review","volume":"8","author":"Lauper","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/1055-9965.EPI-06-0678","article-title":"Genetic variation in the premature aging gene WRN: a case-control study on breast cancer susceptibility","volume":"16","author":"Ding","year":"2007","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib78","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.canlet.2015.01.022","article-title":"Candidate gene analysis of BRCA1\/2 mutation-negative high-risk Russian breast cancer patients","volume":"359","author":"Sokolenko","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.beha.2019.05.001_bib79","series-title":"GeneReviews((R)). Seattle (WA)","article-title":"Werner syndrome","author":"Oshima","year":"1993"},{"key":"10.1016\/j.beha.2019.05.001_bib80","series-title":"GeneReviews((R)). Seattle (WA)","article-title":"Bloom's syndrome","author":"Sanz","year":"1993"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib81","first-page":"754","article-title":"Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs; probably a syndrome entity","volume":"88","author":"Bloom","year":"1954","journal-title":"AMA Am J Dis Child"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib82","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0092-8674(95)90105-1","article-title":"The Bloom's syndrome gene product is homologous to RecQ helicases","volume":"83","author":"Ellis","year":"1995","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/gte.1998.2.293","article-title":"High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin","volume":"2","author":"Shahrabani-Gargir","year":"1998","journal-title":"Genet Test"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib84","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00005792-199311000-00003","article-title":"Bloom syndrome: a mendelian prototype of somatic mutational disease","volume":"72","author":"German","year":"1993","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0165-4608(01)00392-2","article-title":"Chromosomal aberrations in Bloom syndrome patients with myeloid malignancies","volume":"128","author":"Poppe","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib86","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(00)81174-5","article-title":"Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome","volume":"93","author":"Varon","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.beha.2019.05.001_bib87","series-title":"GeneReviews((R)). Seattle (WA)","article-title":"Nijmegen breakage syndrome","author":"Varon","year":"1993"},{"issue":"8\u20139","key":"10.1016\/j.beha.2019.05.001_bib88","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.dnarep.2004.03.004","article-title":"Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks","volume":"3","author":"Digweed","year":"2004","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.beha.2019.05.001_bib89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-7-13","article-title":"Nijmegen breakage syndrome (NBS)","volume":"7","author":"Chrzanowska","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.beha.2019.05.001_bib90","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1210\/jc.2009-2628","article-title":"High prevalence of primary ovarian insufficiency in girls and young women with Nijmegen breakage syndrome: evidence from a longitudinal study","volume":"95","author":"Chrzanowska","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib91","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1067\/mpd.2002.122724","article-title":"Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families","volume":"140","author":"Resnick","year":"2002","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib92","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pbc.21789","article-title":"Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS)","volume":"52","author":"Dembowska-Baginska","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib93","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/bmt.2009.207","article-title":"Successful SCT for Nijmegen breakage syndrome","volume":"45","author":"Albert","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"9199","key":"10.1016\/j.beha.2019.05.001_bib94","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down's syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.beha.2019.05.001_bib95","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/ijc.21518","article-title":"Cancer incidence of persons with Down syndrome in Finland: a population-based study","volume":"118","author":"Patja","year":"2006","journal-title":"Int J Cancer"},{"issue":"Pt 3","key":"10.1016\/j.beha.2019.05.001_bib96","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2788.2006.00862.x","article-title":"The profile and incidence of cancer in Down syndrome","volume":"51","author":"Sullivan","year":"2007","journal-title":"J Intellect Disabil Res JIDR"},{"key":"10.1016\/j.beha.2019.05.001_bib97","first-page":"262","article-title":"Trisomy 21 in neoplastic cells","volume":"7","author":"Mitelman","year":"1990","journal-title":"Am J Med Genet Suppl"},{"issue":"11","key":"10.1016\/j.beha.2019.05.001_bib98","first-page":"1677","article-title":"Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM study group","volume":"10","author":"Creutzig","year":"1996","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib99","first-page":"107","article-title":"Down's syndrome associated with a myeloproliferative disorder","volume":"124","author":"Okada","year":"1972","journal-title":"Am J Dis Child (1960)"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib100","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood-2007-01-069542","article-title":"Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome","volume":"110","author":"Pine","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib101","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.2000.02027.x","article-title":"The management of neoplastic disorders of haematopoiesis in children with Down's syndrome","volume":"110","author":"Lange","year":"2000","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.beha.2019.05.001_bib102","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1182\/blood.V80.9.2210.2210","article-title":"Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498","volume":"80","author":"Ravindranath","year":"1992","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib103","first-page":"608","article-title":"Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: children's Cancer Group Studies 2861 and 2891","volume":"91","author":"Lange","year":"1998","journal-title":"Blood"},{"issue":"34","key":"10.1016\/j.beha.2019.05.001_bib104","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1200\/JCO.2007.12.3687","article-title":"Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group","volume":"25","author":"Kudo","year":"2007","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.beha.2019.05.001_bib105","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/sj.leu.2403814","article-title":"AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity","volume":"19","author":"Creutzig","year":"2005","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib106","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2141.2005.05906.x","article-title":"Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials","volume":"132","author":"Rao","year":"2006","journal-title":"Br J Haematol"},{"issue":"18","key":"10.1016\/j.beha.2019.05.001_bib107","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2003.08.060","article-title":"Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891","volume":"21","author":"Gamis","year":"2003","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib108","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2141.2006.06097.x","article-title":"Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome","volume":"133","author":"Al-Ahmari","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00043426-200201000-00004","article-title":"Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: pediatric oncology group study","volume":"24","author":"Al-Kasim","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00043426-199602000-00011","article-title":"Erythroblastic and\/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine","volume":"18","author":"Tchernia","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib111","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pbc.22943","article-title":"Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study","volume":"57","author":"Taga","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib112","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajmg.c.30300","article-title":"Cancer in noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes","volume":"157C","author":"Kratz","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib113","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ajmg.a.30598","article-title":"Genotypic and phenotypic characterization of Noonan syndrome: new data and review of the literature","volume":"134A","author":"Jongmans","year":"2005","journal-title":"Am J Med Genet Part A"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib114","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/adc.2006.104547","article-title":"The natural history of Noonan syndrome: a long-term follow-up study","volume":"92","author":"Shaw","year":"2007","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajmg.1320210312","article-title":"Noonan syndrome: a review","volume":"21","author":"Mendez","year":"1985","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.beha.2019.05.001_bib116","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.genom.6.080604.162305","article-title":"Noonan syndrome and related disorders: genetics and pathogenesis","volume":"6","author":"Tartaglia","year":"2005","journal-title":"Annu Rev Genom Hum Genet"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib117","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.beha.2019.05.001_bib118","first-page":"8","article-title":"Malignant diseases in Noonan syndrome and related disorders","volume":"72","author":"Hasle","year":"2009","journal-title":"Horm Res"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib119","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-3476(97)70273-7","article-title":"Occurrence of myeloproliferative disorder in patients with Noonan syndrome","volume":"130","author":"Bader-Meunier","year":"1997","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.beha.2019.05.001_bib120","first-page":"3534","article-title":"Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)","volume":"89","author":"Niemeyer","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib121","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.leukres.2008.08.022","article-title":"Juvenile myelomonocytic leukemia: a report from the 2nd International JMML symposium","volume":"33","author":"Chan","year":"2009","journal-title":"Leuk Res"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib122","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V77.5.925.925","article-title":"Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors","volume":"77","author":"Emanuel","year":"1991","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib123","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/MPH.0b013e3180437e18","article-title":"Respiratory failure, juvenile myelomonocytic leukemia, and neonatal Noonan syndrome","volume":"29","author":"Cheong","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib124","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00043426-199911000-00014","article-title":"Juvenile myelomonocytic leukemia and Noonan syndrome","volume":"21","author":"Choong","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00043426-199703000-00019","article-title":"Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome","volume":"19","author":"Fukuda","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib126","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2005-02-0531","article-title":"The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease","volume":"106","author":"Kratz","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib127","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajmg.a.30029","article-title":"A 3-bp deletion mutation of PTPN11 in an infant with severe Noonan syndrome including hydrops fetalis and juvenile myelomonocytic leukemia","volume":"128A","author":"Yoshida","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib128","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib129","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2141.2010.08393.x","article-title":"Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia","volume":"151","author":"Perez","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib131","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0888-7543(90)90199-5","article-title":"Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts","volume":"7","author":"Cawthon","year":"1990","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib132","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"issue":"4965","key":"10.1016\/j.beha.2019.05.001_bib133","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib134","first-page":"841","article-title":"A functional assay for heterozygous mutations in the GTPase activating protein related domain of the neurofibromatosis type 1 gene","volume":"10","author":"Ishioka","year":"1995","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib135","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","article-title":"The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21","volume":"63","author":"Martin","year":"1990","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib136","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(90)90149-9","article-title":"The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae","volume":"63","author":"Xu","year":"1990","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib137","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","article-title":"The neurofibromatosis type 1 gene encodes a protein related to GAP","volume":"62","author":"Xu","year":"1990","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib138","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/bjc.1994.431","article-title":"Neurofibromatosis and childhood leukaemia\/lymphoma: a population-based UKCCSG study","volume":"70","author":"Stiller","year":"1994","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.beha.2019.05.001_bib139","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archderm.1995.01690200040007","article-title":"Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia: world statistical analysis","volume":"131","author":"Zvulunov","year":"1995","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.beha.2019.05.001_bib140","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199403033300903","article-title":"Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders","volume":"330","author":"Shannon","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib141","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","article-title":"Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells","volume":"12","author":"Bollag","year":"1996","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib142","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1097-2765(00)80415-3","article-title":"Nf1 and Gmcsf interact in myeloid leukemogenesis","volume":"5","author":"Birnbaum","year":"2000","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib143","first-page":"492","article-title":"Fanconi anemia","volume":"2011","author":"Soulier","year":"2011","journal-title":"ASH Educ Program B"},{"issue":"11","key":"10.1016\/j.beha.2019.05.001_bib144","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1172\/JCI58321","article-title":"Molecular pathogenesis and clinical management of Fanconi anemia","volume":"122","author":"Kee","year":"2012","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib145","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood.V84.5.1650.1650","article-title":"Hematologic abnormalities in Fanconi anemia: an international Fanconi anemia Registry study [see comments]","volume":"84","author":"Butturini","year":"1994","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib146","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the international Fanconi anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2019.05.001_bib147","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrg2159","article-title":"Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins","volume":"8","author":"Wang","year":"2007","journal-title":"Nat Rev Genet"},{"issue":"5581","key":"10.1016\/j.beha.2019.05.001_bib148","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","article-title":"Biallelic inactivation of BRCA2 in Fanconi anemia","volume":"297","author":"Howlett","year":"2002","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.beha.2019.05.001_bib149","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1182\/blood-2010-09-308726","article-title":"Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions","volume":"117","author":"Quentin","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2019.05.001_bib150","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood.V86.7.2856.2856","article-title":"Bone marrow transplantation for Fanconi anemia","volume":"86","author":"Gluckman","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib151","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2141.2009.07598.x","article-title":"Advances in the understanding of dyskeratosis congenita","volume":"145","author":"Walne","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib152","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat Genet"},{"issue":"6761","key":"10.1016\/j.beha.2019.05.001_bib153","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/990141","article-title":"A telomerase component is defective in the human disease dyskeratosis congenita","volume":"402","author":"Mitchell","year":"1999","journal-title":"Nature"},{"issue":"6854","key":"10.1016\/j.beha.2019.05.001_bib154","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/35096585","article-title":"The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita","volume":"413","author":"Vulliamy","year":"2001","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.beha.2019.05.001_bib155","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa042980","article-title":"Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia","volume":"352","author":"Yamaguchi","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib156","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib157","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1399-3046.2007.00721.x","article-title":"Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation","volume":"11","author":"de la Fuente","year":"2007","journal-title":"Pediatr Transplant"},{"issue":"16","key":"10.1016\/j.beha.2019.05.001_bib158","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","article-title":"Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms","volume":"129","author":"Tesi","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib159","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0022-3476(89)80342-7","article-title":"Ataxia-pancytopenia and monosomy 7 syndrome","volume":"115","author":"Daghistani","year":"1989","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0165-4608(81)90013-3","article-title":"Ataxia-pancytopenia: syndrome of cerebellar ataxia, hypoplastic anemia, monosomy 7, and acute myelogenous leukemia","volume":"4","author":"Li","year":"1981","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib161","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0002-9343(78)90744-1","article-title":"A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: association with bone marrow C-monosomy","volume":"65","author":"Li","year":"1978","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.beha.2019.05.001_bib162","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib163","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1365-2141.2002.03585.x","article-title":"Shwachman-diamond syndrome","volume":"118","author":"Dror","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2019.05.001_bib164","series-title":"Diagnosis, genetics, and management of inherited bone marrow failure syndromes","author":"Alter","year":"2007"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1067\/mpd.2002.125849","article-title":"Serum pancreatic enzymes define the pancreatic phenotype in patients with Shwachman-Diamond syndrome","volume":"141","author":"Ip","year":"2002","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.beha.2019.05.001_bib166","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1067\/mpd.2002.125850","article-title":"Shwachman-Diamond syndrome: report from an international conference","volume":"141","author":"Rothbaum","year":"2002","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.beha.2019.05.001_bib167","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng1062","article-title":"Mutations in SBDS are associated with Shwachman-Diamond syndrome","volume":"33","author":"Boocock","year":"2003","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib168","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ng1994","article-title":"The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast","volume":"39","author":"Menne","year":"2007","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib169","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.seminhematol.2006.04.004","article-title":"Severe congenital neutropenia","volume":"43","author":"Welte","year":"2006","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1016\/j.beha.2019.05.001_bib170","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/70544","article-title":"Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis","volume":"23","author":"Horwitz","year":"1999","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib171","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood-2006-08-019166","article-title":"Neutrophil elastase in cyclic and severe congenital neutropenia","volume":"109","author":"Horwitz","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2019.05.001_bib172","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2141.2012.09171.x","article-title":"Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome\/leukaemia","volume":"158","author":"Carlsson","year":"2012","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.beha.2019.05.001_bib173","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJM198906153202402","article-title":"Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis","volume":"320","author":"Bonilla","year":"1989","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.beha.2019.05.001_bib174","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V75.5.1056.1056","article-title":"Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia","volume":"75","author":"Welte","year":"1990","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.beha.2019.05.001_bib175","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood-2015-02-628859","article-title":"Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation","volume":"126","author":"Fioredda","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2019.05.001_bib176","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2141.2008.07269.x","article-title":"Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference","volume":"142","author":"Vlachos","year":"2008","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.beha.2019.05.001_bib177","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood-2011-08-375972","article-title":"Incidence of neoplasia in diamond Blackfan anemia: a report from the diamond Blackfan anemia Registry","volume":"119","author":"Vlachos","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2019.05.001_bib178","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bmt.2015.117","article-title":"Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes","volume":"50","author":"De Latour","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2019.05.001_bib179","first-page":"333","article-title":"Myelodysplastic syndrome and gastrointestinal carcinomas characterize the cancer risk in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry","volume":"128","author":"Vlachos","year":"2016","journal-title":"Am Soc Hematol"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692619300179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692619300179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:05:50Z","timestamp":1761498350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692619300179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":179,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1521692619300179"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2019.05.001","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary myeloid malignancies","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}